Dupilumab-induced enthesoarthritis and refractory atopic dermatitis successfully treated with baricitinib

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)e64-e66
JournalRheumatology (Oxford, England)
Volume61
Issue number3
DOIs
Publication statusPublished - Mar 2 2022

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this